BRÈVE publiée le 18/11/2025 à 19:11, il y a 11 mois 16 jours Fuller, Smith & Turner PLC Purchases Shares in Buyback Programme London Stock Exchange Ordinary Shares Share Buyback Market Regulation Fuller, Smith & Turner
BRÈVE publiée le 18/11/2025 à 19:11, il y a 11 mois 16 jours Fuller, Smith & Turner PLC acquiert des actions dans le cadre d'un programme de rachat d'actions Rachat D'actions Actions Ordinaires Bourse De Londres Fuller, Smith & Turner Réglementation Du Marché
COMMUNIQUÉ DE PRESSE publié le 18/11/2025 à 19:06, il y a 11 mois 16 jours Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC announces purchase of own shares as part of share buyback program. Company intends to hold repurchased shares in Treasury London Stock Exchange Share Buyback Program Fuller, Smith & Turner PLC Numis Securities Limited Own Shares
BRÈVE publiée le 17/11/2025 à 18:04, il y a 11 mois 17 jours Fuller, Smith & Turner PLC Executes Share Buyback London Stock Exchange Share Buyback Market Abuse Regulation Treasury Shares Fuller's
BRÈVE publiée le 17/11/2025 à 18:04, il y a 11 mois 17 jours Fuller, Smith & Turner PLC procède à un rachat d'actions Rachat D'actions Bourse De Londres Fuller's Réglementation Des Abus De Marché Actions Du Trésor
COMMUNIQUÉ DE PRESSE publié le 17/11/2025 à 17:59, il y a 11 mois 17 jours Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC announces the purchase of 20,000 of its 'A' Ordinary Shares on the London Stock Exchange as part of its buyback program London Stock Exchange Share Buyback Program Fuller, Smith & Turner PLC Own Shares Purchase
BRÈVE publiée le 17/11/2025 à 17:43, il y a 11 mois 17 jours Fuller, Smith & Turner: Director Share Sale Notification Shareholding PDMR Notification Fuller, Smith & Turner Richard Fuller London Transaction
BRÈVE publiée le 17/11/2025 à 17:43, il y a 11 mois 17 jours Fuller, Smith & Turner : Notification de vente d'actions par les administrateurs Actionnariat Fuller, Smith & Turner Notification PDMR Richard Fuller Transaction Londonienne
COMMUNIQUÉ DE PRESSE publié le 17/11/2025 à 17:38, il y a 11 mois 17 jours Fuller, Smith & Turner PLC: Director / PDMR Shareholding Fuller, Smith & Turner PLC announces Director, Richard Fuller's sale of 5,000 'A' Ordinary Shares at £6.51 per share on 13 Nov 2025 in compliance with Market Abuse Regulation PDMR Director Shareholding Fuller Smith Turner PLC EU Market Abuse Regulation Richard Fuller
BRÈVE publiée le 14/11/2025 à 17:59, il y a 11 mois 20 jours Fuller, Smith & Turner PLC: Recent Share Buyback Activity London Stock Exchange Ordinary Shares Share Buyback Fuller, Smith & Turner PLC Treasury Shares
Publié le 04/11/2026 à 18:00, il y a 6 heures 45 minutes The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026
Publié le 04/11/2026 à 18:00, il y a 6 heures 45 minutes L’État belge et le groupe ENGIE ont convenu de se donner un délai supplémentaire jusqu’au 12 décembre 2026 pour la conclusion des Heads of Terms
Publié le 04/11/2026 à 17:44, il y a 7 heures 1 minute Aéroports de Paris SA - Information regarding the voting rights and shares as of 31 October 2026
Publié le 04/11/2026 à 23:10, il y a 1 heure 35 minutes Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Publié le 04/11/2026 à 23:00, il y a 1 heure 45 minutes Viemed Healthcare Announces Third Quarter 2026 Financial Results
Publié le 04/11/2026 à 22:15, il y a 2 heures 30 minutes Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Publié le 04/11/2026 à 22:05, il y a 2 heures 40 minutes Stabilis Solutions Announces Third Quarter 2026 Results
Publié le 05/11/2026 à 00:02, il y a 42 minutes EQS-Adhoc: NEXTDC Limited: Response to Share Raid by Goodman Group and Digital Realty
Publié le 04/11/2026 à 19:41, il y a 5 heures 4 minutes EQS-Adhoc: SNP SE Raises Outlook for the Full Year 2026
Publié le 04/11/2026 à 19:25, il y a 5 heures 20 minutes Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study of dapolsertib (MEN1703, SEL24) in Heavily Pretreated Relapsed/Refractory Aggressive B-cell non-Hodgkin Lymphoma at the 2026 ASH Annual Meeting
Publié le 04/11/2026 à 18:43, il y a 6 heures 2 minutes EQS-Adhoc: Deutsche EuroShop refines its revenue forecast and raises its earnings forecast for the 2026 financial year
Publié le 04/11/2026 à 18:05, il y a 6 heures 40 minutes Redis Expands Redis Iris to Give AI Agents the Memory, Context, and Messaging They Need to get to Production
